
Liquidity, historical trends, and peer comparisons.
According to ABL Diagnostics Société anonyme’s latest financial reports and current stock price. The company's current Current Ratio is 28.79. This represents a change of -71.85% compared to the average of 102.25 of the last 4 quarters.
The mean historical Current Ratio of ABL Diagnostics Société anonyme over the last ten years is 67.96. The current 28.79 Current Ratio has changed -57.64% with respect to the historical average. Over the past ten years (40 quarters), ABLD.PA's Current Ratio was at its highest in in the June 2019 quarter at 456.54. The Current Ratio was at its lowest in in the March 2010 quarter at 0.
Average
67.96
Median
22.33
Minimum
3.95
Maximum
393.63
Discovering the peaks and valleys of ABL Diagnostics Société anonyme Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 393.63
Minimum Annual Increase = -87.63%
Minimum Annual Current Ratio = 3.95
| Year | Current Ratio | Change |
|---|---|---|
| 2021 | 28.79 | -78.09% |
| 2020 | 131.37 | -66.63% |
| 2019 | 393.63 | 2.92% |
| 2018 | 13.05 | -50.79% |
| 2017 | 26.51 | 46.09% |
| 2016 | 18.15 | 359.79% |
| 2015 | 3.95 | -87.63% |
| 2014 | 31.91 | 120.36% |
| 2013 | 14.48 | -18.45% |
| 2012 | 17.76 | Infinity% |
The current Current Ratio of ABL Diagnostics Société anonyme (ABLD.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
184.59
5-year avg
118.67
10-year avg
67.96
ABL Diagnostics Société anonyme’s Current Ratio is greater than ABIONYX Pharma S.A. (5.03), greater than Baikowski S.A. (2.02), greater than Advicenne S.A. (0.80), greater than NSE S.A. (1.80), greater than Poujoulat S.A. (1.56), greater than GE HealthCare Technologies Inc. (1.02),
| Company | Current Ratio | Market cap |
|---|---|---|
| 5.03 | $70.27M | |
| 2.02 | $68.24M | |
| 0.80 | $9.17M | |
| 1.80 | $116.33M | |
| 1.56 | $42.08M | |
| 1.02 | $32.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABL Diagnostics Société anonyme using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ABL Diagnostics Société anonyme or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ABL Diagnostics Société anonyme's Current Ratio?
How is the Current Ratio calculated for ABL Diagnostics Société anonyme (ABLD.PA)?
What is the highest Current Ratio for ABL Diagnostics Société anonyme (ABLD.PA)?
What is the 3-year average Current Ratio for ABL Diagnostics Société anonyme (ABLD.PA)?
What is the 5-year average Current Ratio for ABL Diagnostics Société anonyme (ABLD.PA)?
How does the current Current Ratio for ABL Diagnostics Société anonyme (ABLD.PA) compare to its historical average?